Charging Robotics Sells 51% of Core Subsidiary to Clearmind Medicine for $2.5M
CHEV has more than doubled off its 52-week low of $0.11.
Summary
Charging Robotics Inc. agreed to sell 51% of its wholly owned subsidiary Charging Israel to Clearmind Medicine Inc. for $2.5 million, plus a $1.5 million loan. The company will retain 49% ownership and deconsolidate the subsidiary.
Key Events · M&A and Partnerships · CHEV
-
Majority Stake Sale to Clearmind Medicine
Clearmind Medicine Inc. agreed to purchase 149 ordinary shares of Charging Israel for $2.5 million ($16,778 per share), acquiring 51% ownership. Charging Robotics retains 49%.
-
$1.5M Loan Facility
Clearmind will provide a $1.5 million loan to Charging Israel at 4.0% annual interest, maturing in three years with automatic extension if positive cash flow is not achieved.
-
Deconsolidation Impact
Charging Israel will cease to be a consolidated subsidiary. Pro forma financials show a $4.865 million gain on deconsolidation for the year ended December 31, 2025.
-
Cash Position Remains Critical
The parent company's cash balance was only $10 thousand as of the last 10-Q filed August 13, 2026, with a going concern warning. The transaction proceeds go to Charging Israel, not directly to the parent.
Analysis · CHEV · Trade & Services
Charging Robotics is selling majority control of its operating subsidiary, Charging Israel, to Clearmind Medicine for $2.5 million in equity plus a $1.5 million loan. The company retains 49% but loses consolidation, meaning its financial statements will no longer include Charging Israel's operations. The pro forma shows a $4.865 million gain on deconsolidation, but the company's cash position remains critically weak at just $10 thousand as of the last 10-Q. This transaction provides immediate liquidity to the subsidiary but fundamentally changes the parent company's structure and future revenue potential.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHEV was trading at $0.30 on OTC in the Trade & Services sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $0.11 to $9,000.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.